Feng Yang

发表

Developing a Novel Indium(III) Agent Based on Liposomes to Overcome Cisplatin-Induced Resistance in Breast Cancer by Multitargeting the Tumor Microenvironment Components.

Ming Jiang, Yong Chu, Tongfu Yang, 2021, Journal of medicinal chemistry.

Solution, solid state, and film properties of a structurally characterized highly luminescent molecular europium plastic material excitable with visible light.

M. Ephritikhine, P. Thuéry, Feng Yang, 2011, Inorganic chemistry.

Human serum albumin-based dual-agent delivery systems for combination therapy: acting against cancer cells and inhibiting neovascularization in the tumor microenvironment.

Ming Jiang, Zhenlei Zhang, Hongbin Sun, 2020, Molecular pharmaceutics.

Developing an Anticancer Copper(II) Pro-Drug Based on the His242 Residue of the Human Serum Albumin Carrier IIA Subdomain.

Zhenlei Zhang, Hong Liang, Feng Yang, 2016, Molecular pharmaceutics.

Developing a binuclear multi-target Bi(III) complex by optimizing 2-acetyl-3-ethylpyrazine thiosemicarbazides.

Zhenlei Zhang, Hongbin Sun, Hong Liang, 2019, European journal of medicinal chemistry.

Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.

Yani Liu, Feng Yang, Y. Gou, 2018, European journal of medicinal chemistry.

Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents.

Feng Yang, Gui-Fa Su, Huang Tang, 2014, European journal of medicinal chemistry.

Current status of iridium-based complexes against lung cancer

Minghui Zhu, Ming Jiang, Tongfu Yang, 2022, Frontiers in Pharmacology.

High and balanced hole and electron mobilities from ambipolar thin-film transistors based on nitrogen-containing oligoacences.

X. Gong, Hao‐Li Zhang, Kai-Ge Zhou, 2010, Journal of the American Chemical Society.

Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis.

Ming Jiang, Zhenlei Zhang, Hongbin Sun, 2020, Journal of medicinal chemistry.

Designing anticancer multitarget metal thiosemicarbazone prodrug based on the nature of binding sites of human serum albumin carrier.

Hong Liang, Feng Yang, 2018, Future medicinal chemistry.

HSA IIA subdomain-based developing anticancer metal prodrug: a new and improved approach.

Hong Liang, Feng Yang, 2016, Future medicinal chemistry.

α-N-heterocyclic thiosemicarbazone Fe(III) complex: Characterization of its antitumor activity and identification of anticancer mechanism.

Feng Yang, Wei S Zhang, Y. Gou, 2016, European journal of medicinal chemistry.

Dithiocarbazate-FeIII, -CoIII, -NiII, and -ZnII Complexes: Design, Synthesis, Structure, and Anticancer Evaluation.

Hao Jiang, Feng Yang, Y. Gou, 2022, Journal of medicinal chemistry.

Folate-functionalized human serum albumin carrier for anticancer copper(II) complexes derived from natural plumbagin.

Hong Liang, Feng Yang, Y. Gou, 2015, Journal of inorganic biochemistry.

Enhancing the copper(II) complexes cytotoxicity to cancer cells through bound to human serum albumin.

Hong Liang, Feng Yang, Y. Gou, 2015, Journal of inorganic biochemistry.

Four copper(II) compounds synthesized by anion regulation: Structure, anticancer function and anticancer mechanism.

Zhenlei Zhang, Hong Liang, Feng Yang, 2016, European journal of medicinal chemistry.

Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism.

Zhenlei Zhang, Hong Liang, Feng Yang, 2015, European journal of medicinal chemistry.

Versatile delivery systems for non-platinum metal-based anticancer therapeutic agents

Hong Liang, Feng Yang, Guojin Huang, 2021 .

Novel Pt(ii) complexes with modified aroyl-hydrazone Schiff-base ligands: synthesis, cytotoxicity and action mechanism.

Zhenlei Zhang, Hong Liang, Feng Yang, 2019, Metallomics : integrated biometal science.

Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer

Hong Liang, Feng Yang, Xiaoyang Wu, 2016, Oncotarget.

Developing Anticancer Copper(II) Pro-drugs Based on the Nature of Cancer Cells and the Human Serum Albumin Carrier IIA Subdomain.

Hong Liang, Feng Yang, Xiaoyang Wu, 2015, Molecular pharmaceutics.

Developing Anticancer Ferric Prodrugs Based on the N-Donor Residues of Human Serum Albumin Carrier IIA Subdomain.

Feng Yang, Xiaoyang Wu, Li Liu, 2016, Journal of medicinal chemistry.

Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents.

Feng Yang, Bohui Xu, Jinlong Li, 2017, European journal of medicinal chemistry.

Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands.

Zhenlei Zhang, Hongbin Sun, Hong Liang, 2018, European journal of medicinal chemistry.

Binding and Anticancer Properties of Plumbagin with Human Serum Albumin

Hong Liang, Feng Yang, Y. Gou, 2015, Chemical biology & drug design.

DNA binding, cytotoxicity and apoptosis induction activity of a mixed-ligand copper(II) complex with taurine Schiff base and imidazole.

Hong Liang, Feng Yang, Mei Li, 2014, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

Developing a Novel Anticancer Gold(III) Agent to Integrate Chemotherapy and Immunotherapy.

Ming Jiang, Zhenlei Zhang, Hongbin Sun, 2021, Journal of medicinal chemistry.

Structure and biological properties of five Pt(II) complexes as potential anticancer agents.

Hong Liang, Feng Yang, Jungang Deng, 2018, Journal of inorganic biochemistry.

Anticancer Function and ROS-Mediated Multi-Targeting Anticancer Mechanisms of Copper (II) 2-hydroxy-1-naphthaldehyde Complexes

Hong Liang, Feng Yang, Jungang Deng, 2019, Molecules.

Anticancer and biological properties of a Zn-2,6-diacetylpyridine bis(thiosemicarbazone) complex.

Zhenlei Zhang, Hong Liang, Feng Yang, 2019, Metallomics : integrated biometal science.

Synthesis, structure, protein binding, and cytotoxicity of zinc(II) complexes with tridentate NNO Schiff-base ligands

Hong Liang, Feng Yang, Mei Li, 2014 .

A novel brain-tumor-inhibiting copper(II) compound based on a human serum albumin (HSA)-cell penetrating peptide conjugate.

Zhenlei Zhang, Hongbin Sun, Hong Liang, 2019, Journal of medicinal chemistry.

Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier.

Zhenlei Zhang, Hong Liang, Feng Yang, 2017, Molecular pharmaceutics.

Synthesis of a series of novel In(III) 2,6-diacetylpyridine bis(thiosemicarbazide) complexes: structure, anticancer function and mechanism.

Ming Jiang, Zhenlei Zhang, Hong Liang, 2020, Dalton transactions.

Development of a multi-target anticancer Sn(II) pyridine-2-carboxaldehyde thiosemicarbazone complex.

Tongfu Yang, Wenjuan Li, Hongbin Sun, 2021, Dalton transactions.

Interactive Association of Drugs Binding to Human Serum Albumin

Hong Liang, Feng Yang, Yao Zhang, 2014, International journal of molecular sciences.

Effect of human serum albumin on drug metabolism: structural evidence of esterase activity of human serum albumin.

Feng Yang, Mingdong Huang, C. Bian, 2007, Journal of structural biology.

Designing biotin-human serum albumin nanoparticles to enhance the targeting ability of binuclear ruthenium(III) compound.

Ming Jiang, Wenjuan Li, Hong Liang, 2020, Journal of inorganic biochemistry.

Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albumin.

Ming Jiang, Zhenlei Zhang, Hong Liang, 2017, Journal of inorganic biochemistry.

Local Anesthetics Induce Apoptosis in Human Breast Tumor Cells

Feng Yang, Ming‐Jen Chen, Y. Hsu, 2014, Anesthesia and analgesia.

Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer.

Guihua Fang, Feng Yang, Meirong Chen, 2021, Journal of medicinal chemistry.

Synthesis of tetrachloro-azapentacene as an ambipolar organic semiconductor with high and balanced carrier mobilities.

X. Gong, Hao‐Li Zhang, Feng Yang, 2011, Organic letters.

Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and Therapy.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2022, Journal of medicinal chemistry.

Developing a Gallium(III) Agent Based on the Properties of the Tumor Microenvironment and Lactoferrin: Achieving Two-Agent Co-delivery and Multi-targeted Combination Therapy of Cancer.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2022, Journal of medicinal chemistry.

Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer.

Ming Jiang, Wenjuan Li, Zhenlei Zhang, 2022, Journal of medicinal chemistry.

Organometallic gold(I) and gold(III) complexes for lung cancer treatment

Feng Yang, Jian Chen, Juzheng Zhang, 2022, Frontiers in Pharmacology.

Multidrug Delivery Systems Based on Human Serum Albumin for Combination Therapy with Three Anticancer Agents.

Hong Liang, Feng Yang, Philbert Lee, 2016, Molecular pharmaceutics.

18β-glycyrrhetinic Acid-induced Apoptosis and Relation with Intracellular Ca2+ Release in Human Breast Carcinoma Cells

Feng Yang, Qinian Wu, Zhiling Zhang, 2004 .

Structural basis and anticancer properties of ruthenium-based drug complexed with human serum albumin.

Hong Liang, Feng Yang, J. Yue, 2014, European journal of medicinal chemistry.

Mitochondria-localizing N-heterocyclic thiosemicarbazone copper complexes with good cytotoxicity and high antimetastatic activity.

Yani Liu, Feng Yang, Y. Gou, 2019, European journal of medicinal chemistry.

Designing Prodrugs Based on Special Residues of Human Serum Albumin.

Hong Liang, Feng Yang, Y. Gou, 2015, Current topics in medicinal chemistry.

Structural Basis of Non‐Steroidal Anti‐Inflammatory Drug Diclofenac Binding to Human Serum Albumin

Hong Liang, Feng Yang, Philbert Lee, 2015, Chemical biology & drug design.

Comparison of Binding Characterization of Two Antiviral Drugs to Human Serum Albumin

Hong Liang, Feng Yang, Xiaoyang Wu, 2014, Chemical biology & drug design.

Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin.

Tongfu Yang, Zhenlei Zhang, Hong Liang, 2023, Journal of medicinal chemistry.

Developing a Multitargeted Anticancer Palladium(II) Agent Based on the His-242 Residue in the IIA Subdomain of Human Serum Albumin.

Wenjuan Li, Zhenlei Zhang, Hong Liang, 2023, Journal of medicinal chemistry.

X‐ray Crystallographic and Fluorometric Analysis of the Interactions of Rhein to Human Serum Albumin

Hong Liang, Feng Yang, Philbert Lee, 2014, Chemical biology & drug design.

Human serum albumin-based design of a diflunisal prodrug.

O. Lockridge, Hong Liang, Feng Yang, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Interactive associations of drug-drug and drug-drug-drug with IIA subdomain of human serum albumin.

Hong Liang, Feng Yang, J. Yue, 2012, Molecular pharmaceutics.

Regulation of amantadine hydrochloride binding with IIA subdomain of human serum albumin by fatty acid chains.

Hong Liang, Feng Yang, Philbert Lee, 2013, Journal of pharmaceutical sciences.

Synthesis and photobiological study of a novel chlorin photosensitizer BCPD-18MA for photodynamic therapy.

Wei Liu, Yingying Zhang, Li Deng, 2011, Bioorganic & medicinal chemistry.

Developing Anticancer Copper(II) Pro-drugs Based on the Nature of Cancer Cells and the Human Serum Albumin Carrier IIA Subdomain.

Hong Liang, Feng Yang, Xiaoyang Wu, 2015, Molecular pharmaceutics.

Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of Cancer.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2023, Journal of medicinal chemistry.

Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albumin.

Ming Jiang, Zhenlei Zhang, Hong Liang, 2017, Journal of inorganic biochemistry.

Encapsulation of Au(III) Complex Using Lactoferrin Nanoparticles to Combat Glioma.

Feng Yang, Juzheng Zhang, Jian Chen, 2023, Molecular pharmaceutics.

Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier.

Zhenlei Zhang, Hong Liang, Feng Yang, 2017, Molecular pharmaceutics.

Predictive In Vitro Vitreous and Serum Models and Methods to Assess Thiol-related Quality Attributes in Protein Therapeutics.

Yan Chen, Feng Yang, Y. D. Liu, 2020, Analytical chemistry.

Developing a Ruthenium(III) Complex to Trigger Gasdermin E-Mediated Pyroptosis and an Immune Response Based on Decitabine and Liposomes: Targeting Inhibition of Gastric Tumor Growth and Metastasis.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2023, Journal of medicinal chemistry.